Mouse IgA modulates human gut microbiota with inflammatory bowel disease patients.

Keishu TakahashiNaoki MoritaRyutaro TamanoPeng GaoNoriho IidaAkira AndohHirotsugu ImaedaKen KurokawaMayo TsuboiYoku HayakawaMitsuhiro FujishiroReiko Shinkura

Published in: Journal of gastroenterology (2024)

Oral treatment of mouse IgA can treat gut dysbiosis in IBD patients by modulating gut microbiota.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
endothelial cells
signaling pathway
patient reported outcomes